Biokad Company was founded in 2001 and currently has three research centers in Moscow region and St. Petersburg. It uses innovative biotechnologies in pharmaceutical production, conducts clinical and preclinical research in accordance with international standards GLP/GCP. The entire production process is adjusted to the international standards of GMP, and the creation of drugs goes through the entire production cycle from the search for a molecule using computer simulation to the introduction into mass production of the finished product, which has passed a number of complex tests. The staff of scientists is made up of the best specialists in chemistry, biochemistry, genetic engineering, etc. The main focus of the company is concentrated on the creation of original and reproduced drugs for the treatment of oncology, infectious and autoimmune diseases. Biocad produces 58 own medicines, 16 of which are biological.
The company employs more than 2200 people, 880 of whom are scientists.
Own research centers and laboratories equipped with high-tech equipment.
Full cycle of drug development based on computer simulation and genetic engineering.